Preview Mode Links will not work in preview mode

Jan 19, 2021

Featuring an interview with Dr Shannon N Westin on the following topics:

  • Evolving role of PARP inhibition in the management of ovarian cancer (OC) (0:00)
  • Frequency and clinical significance of germline and somatic BRCA mutations and other genomic signatures that may predict benefit from PARP inhibition (3:46)
  • Pivotal...


Dec 30, 2020

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in gynecologic cancer. Featuring perspectives from Drs Kathleen Moore and David M O’Malley, including the following topics:

  • Introduction
  • MSI-High/dMMR or MSS Endometrial...


Dec 11, 2020

Featuring a discussion on the current and future role of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers with Dr David O’Malley, including the following topics:

  • Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of...


Dec 3, 2020

This program includes faculty lectures by Drs David O’Malley of The Ohio State University on immune checkpoint inhibition for cervical and endometrial cancer and Shannon Westin of The University of Texas MD Anderson Cancer Center on PARP inhibitors and ovarian cancer. Access NCPD information and select publications...


Dec 3, 2020

Special nursing program focused on gynecologic cancers. This program includes case discussions from the practices of Paula J Anastasia, RN, MN, AOCN and Jennifer Filipi, MSN, NP. Access NCPD information and select publications here.

  • Case (Ms Anastasia): A woman in her early 60s with ovarian cancer
  • Case (Ms Anastasia):...